2025 ASTRO Class of Fellows

Forty-three distinguished members of the American Society for Radiation Oncology have been selected to receive the ASTRO Fellow (FASTRO) designation. The ASTRO Fellows program recognizes members who have made outstanding achievements and contributions to the Society, cancer research, education, patient care and the specialty. The class of 2025 Fellows will be conferred during the Awards Ceremony on Tuesday, September 30, in San Francisco.

ASTRO is proud to announce the 2025 class of Fellows:

• Jonathan Ashman, MD, PhD, Mayo Clinic, Phoenix, Arizona
• Stanley Benedict, PhD, Virginia Commonwealth University, Richmond, Virginia
• Higinia Rosa Cardenes Perera, MD, PhD, New York Presbyterian, Weill Cornell Medical Center, New York, New York
• Annie W. Chan, MD, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts
• Zhe (Jay) Chen, PhD, Yale University School of Medicine, New Haven, Connecticut
• Jennifer F. De Los Santos, MD, Washington University School of Medicine in St. Louis, Saint Louis, Missouri
• Hans Theodor Eich, MD, PhD, University Hospital Muenster, Muenster, Germany
• Moataz N. El-Ghamry, MD, Baylor Scott and White Health, Temple, Texas
• Clifton D. Fuller, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, Texas
• Daniel R. Gomez, MD, MBA, Memorial Sloan Kettering Cancer Center, New York, New York
• Chandan Guha, MD, PhD, MBBS, Montefiore Medical Center, Albert Einstein College of Medicine, New York, New York
• Ying J. Hitchcock, MD, University of Utah Huntsman Cancer Institute, Salt Lake City, Utah
• Kathleen Horst, MD, Stanford University, Stanford, California
• Geoffrey Hugo, PhD, Washington University School of Medicine in St. Louis, Saint Louis, Missouri
• Christopher Jahraus, MD, Generations Radiotherapy and Oncology PC, Alabaster, Alabama
• Rachel Jimenez, MD, Massachusetts General Hospital, Boston, Massachusetts
• Melissa M. Joyner, MD, MBA, The University of Texas MD Anderson Cancer Center, Houston, Texas
• Brent Kane, MD, Community Cancer Institute, Clovis, California
• Elizabeth Kidd, MD, Stanford University, Stanford, California
• Daniel J. Krauss, MD, Corewell Health Beaumont University Hospital, Royal Oak, Michigan
• Nicole A. Larrier, MD, MS, Duke University, Durham, North Carolina
• Steven H. Lin, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, Texas
• Janice Lyons, MD, University Hospitals, Seidman Cancer Center, Cleveland, Ohio
• Chika N. Madu, MD, Northwell Health, Staten Island, New York
• Heyoung Lee McBride, MD, MS, Tampa General Hospital Cancer Institute/University of South Florida Morsani School of Medicine, Tampa, Florida
• Joshua Meyer, MD, Fox Chase Cancer Center, Philadelphia, Pennsylvania
• Drew Moghanaki, MD, MPH, UCLA David Geffen School of Medicine at UCLA, Los Angeles, California
• Sabin B. Motwani, MD, Rutgers Cancer Institute and RWJBarnabas, Jersey City, New Jersey
• Subhakar Mutyala, MD, MBA, MPH, Arizona Center for Cancer Care, Phoenix, Arizona
• Kenneth Olivier, MD, Mayo Clinic College of Medicine and Science Rochester, Rochester, Minnesota
• Harald Paganetti, PhD, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts
• Rahul Parikh, MD, MBA, Rutgers Cancer Institute, New Brunswick, New Jersey
• John Plastaras, MD, PhD, University of Pennsylvania, Philadelphia, Pennsylvania
• Andreas Rimner, MD, University of Freiburg, Freiburg, Germany
• Mihaela Rosu-Bubulac, PhD, Virginia Commonwealth University, Richmond, Virginia
• Narayan Sahoo, PhD, The University of Texas MD Anderson Cancer Center, Houston, Texas
• Parag Sanghvi, MD, MSPH, University of California, San Diego, La Jolla, California
• Naomi Schechter, MD, South Florida Proton Therapy Institute, Delray Beach, Florida
• Farzan Siddiqui, MD, PhD, Henry Ford Health, Detroit, Michigan
• Gita Suneja, MD, MS, University of Utah, Salt Lake City, Utah
• Andrew Z. Wang, MD, University of Texas Southwestern Medical Center, Dallas, Texas
• Jennifer Wo, MD, Massachusetts General Brigham, Boston, Massachusetts
• Rebecca KS Wong, MBChB, MSc, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Don’t miss the Awards Ceremony on Tuesday, September 30, in San Francisco at 10:00 a.m.